keyword
https://read.qxmd.com/read/38597217/atypical-chemokine-receptor-4-ackr4-ccx-ckr-a-comprehensive-exploration-across-physiological-and-pathological-landscapes-in-contemporary-research
#41
REVIEW
Israa Habeeb Naser, Asia Ali Hamza, Ahmed Alhili, Ahmed Naser Faisal, Mohammed Shnain Ali, Noor Abdulaala Kadhim, Muath Suliman, Mohammad Y Alshahrani, Ahmed Alawadi
Atypical chemokine receptor 4 (ACKR4), also known as CCX-CKR, is a member of the chemokine receptor family that lacks typical G protein signaling activity. Instead, ACKR4 functions as a scavenger receptor that can bind and internalize a wide range of chemokines, influencing their availability and activity in the body. ACKR4 is involved in various physiological processes, such as immune cell trafficking and the development of thymus, spleen, and lymph nodes. Moreover, ACKR4 has been implicated in several pathological conditions, including cancer, heart and lung diseases...
April 2024: Cell Biochemistry and Function
https://read.qxmd.com/read/38595817/sacituzumab-govitecan-for-the-treatment-of-advanced-triple-negative-breast-cancer-patients-a-multi-center-real-world-analysis
#42
JOURNAL ARTICLE
Roberta Caputo, Giuseppe Buono, Michela Piezzo, Claudia Martinelli, Daniela Cianniello, Alessandro Rizzo, Francesco Pantano, Nicoletta Staropoli, Rodolfo Cangiano, Salvatore Turano, Ida Paris, Francesco Nuzzo, Alessandra Fabi, Michelino De Laurentiis
OBJECTIVE: The objective of this multicenter, observational, retrospective analysis was to evaluate the safety and efficacy of sacituzumab govitecan in metastatic triple-negative breast cancer (mTNBC) patients managed according to common clinical practice in Italy. METHODS: Data were retrieved by 7 sites. Triple-negative BC was defined by the lack of expression of estrogen receptor (ER <1%), progesterone receptor (PgR <1%) and human-epidermal growth factor receptor-2 (HER2 0, 1+, 2+ ISH-not amplified) according to standard ASCO-CAP criteria...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38595728/urinary-bladder-metastasis-from-breast-cancer-a-rare-case-report
#43
Hiroki Oshiro, Yousuke Shimizu, Ryota Nakayasu, Yu Miyazaki, Noriaki Utsunomiya, Satsuki Asai, Sojun Kanamaru
Breast cancer is a major contributor to cancer-related morbidity and mortality in women, which is primarily attributed to metastases. Common metastatic sites include the lungs, liver, and bone, whereas bladder metastasis is rare. We report a case of bladder metastasis from breast cancer in a 61-year-old woman, highlighting the challenges in diagnosis and treatment. The patient, previously diagnosed with invasive lobular carcinoma, presented with renal failure and underwent transurethral resection of bladder tumor...
May 2024: Urology Case Reports
https://read.qxmd.com/read/38594748/a-phenotypic-screening-approach-to-target-p60amotl2-expressing-invasive-cancer-cells
#44
JOURNAL ARTICLE
Pedro Fonseca, Weiyingqi Cui, Nona Struyf, Le Tong, Ayushi Chaurasiya, Felipe Casagrande, Honglei Zhao, Dinura Fernando, Xinsong Chen, Nicholas P Tobin, Brinton Seashore-Ludlow, Andreas Lundqvist, Johan Hartman, Anita Göndör, Päivi Östling, Lars Holmgren
BACKGROUND: Tumor cells have the ability to invade and form small clusters that protrude into adjacent tissues, a phenomenon that is frequently observed at the periphery of a tumor as it expands into healthy tissues. The presence of these clusters is linked to poor prognosis and has proven challenging to treat using conventional therapies. We previously reported that p60AmotL2 expression is localized to invasive colon and breast cancer cells. In vitro, p60AmotL2 promotes epithelial cell invasion by negatively impacting E-cadherin/AmotL2-related mechanotransduction...
April 9, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38586673/hypermetabolic-pulmonary-and-mediastinal-lesions-with-elevated-cancer-antigen-ca-15-3-and-ca-27-29-in-a-patient-with-a-history-of-ovarian-and-breast-cancer
#45
Sindhaghatta Venkatram, Maria Duran, Ked Fortuzi, Aam Baqui, Thanh-Ha Luong, Gilda Diaz-Fuentes
Breast cancer affects around 13% of women. Breast cancer gene 1 ( BRCA1 ) carriers are prone to lung and lymph node metastasis, while breast cancer gene 2 ( BRCA2 ) carriers tend to have bone metastasis. Findings of pulmonary nodules, mediastinal lymphadenopathy, and elevated markers such as cancer antigen (CA) 15-3 and CA 27-29 suggest metastatic disease. Here, we present the case of a patient with BRCA1 -positive breast cancer in remission and a history of ovarian cancer with mediastinal lymphadenopathy and pulmonary nodules, with avid fluorodeoxyglucose uptake on positron emission tomography (PET) scan and elevated CA 15-3 and CA 27-29...
March 2024: Curēus
https://read.qxmd.com/read/38585688/macrophage-heterogeneity-in-bone-metastasis
#46
JOURNAL ARTICLE
Jingxuan Guo, Ruo-Yu Ma, Bin-Zhi Qian
Previous studies illustrated that macrophage, a type of innate immune cell, plays critical roles in tumour progression and metastasis. Bone is the most frequent site of metastasis for several cancer types including breast, prostate, and lung. In bone metastasis, osteoclast, a macrophage subset specialized in bone resorption, was heavily investigated in the past. Recent studies illustrated that other macrophage subsets, e.g. monocyte-derived macrophages, and bone resident macrophages, promoted bone metastasis independent of osteoclast function...
April 2024: Journal of Bone Oncology
https://read.qxmd.com/read/38585006/comparison-of-the-relative-diagnostic-performance-of-68-ga-dota-iba-and-18-f-naf-for-the-detection-of-bone-metastasis
#47
JOURNAL ARTICLE
Jia Deng, Jian Yang, Yingwei Wang, Guangfu Liu, Yue Chen
PURPOSE: We aimed to compare the relative diagnostic efficacy of 68 Ga-Labeled DOTA-ibandronic acid (68 Ga-DOTA-IBA) to that of18 F-NaF PET/CT as a mean of detecting bone metastases in patients with a range of cancer types. METHODS: This study retrospectively enrolled patients with bone metastases associated with various underlying malignancies. All patients underwent both 68 Ga-DOTA-IBA and 18 F-NaF PET/CT scans. Histopathology and follow-up CT or MRI imaging results were used as reference criteria, with a minimum follow-up period of 3 months...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38582932/co-delivery-of-cas9-mrna-and-guide-rnas-for-editing-of-lgmn-gene-represses-breast-cancer-cell-metastasis
#48
JOURNAL ARTICLE
Yue Wang, Yatu Peng, Guanghui Zi, Jin Chen, Baowei Peng
Legumain (or asparagine endopeptidase/AEP) is a lysosomal cysteine endopeptidase associated with increased invasive and migratory behavior in a variety of cancers. In this study, co-delivery of Cas9 mRNA and guide RNA (gRNA) by lipid nanoparticles (LNP) for editing of LGMN gene was performed. For in-vitro transcription (IVT) of gRNA, two templates were designed: linearized pUC57-T7-gRNA and T7-gRNA oligos, and the effectiveness of gRNA was verified in multiple ways. Cas9 plasmid was modified and optimized for IVT of Cas9 mRNA...
April 6, 2024: Scientific Reports
https://read.qxmd.com/read/38581619/lung-derived-soluble-factors-support-stemness-plasticity-and-metastatic-behaviour-of-breast-cancer-cells-via-the-fgf2-dach1-axis
#49
JOURNAL ARTICLE
Vasudeva Bhat, Matthew Piaseczny, David Goodale, Urvi Patel, Ashkan Sadri, Alison L Allan
Patients with triple-negative breast cancer (TNBC) have an increased propensity to develop lung metastasis. Our previous studies demonstrated that stem-like ALDHhi CD44+ breast cancer cells interact with lung-derived soluble factors, resulting in enhanced migration and lung metastasis particularly in TNBC models. We have also observed that the presence of a primary TNBC tumor can 'prime' the lung microenvironment in preparation for metastasis. In this study, we hypothesized that soluble lung-derived factors secreted in the presence of a primary TNBC tumor can influence stemness/plasticity of breast cancer cells...
April 6, 2024: Clinical & Experimental Metastasis
https://read.qxmd.com/read/38577329/renal-pelvis-metastasis-following-surgery-for-breast-angiosarcoma-a-case-report-and-literature-review
#50
Fuyu Guo, Shiwei Sun, Xiangnan Niu, Yue Wang, Wei Yao, Peng Yue, Xiaoqian Deng, Jiwen Shang, Yangang Zhang
Renal metastasis of breast angiosarcoma is rare. This article reports the medical records of a patient diagnosed with breast angiosarcoma who underwent radical mastectomy and was found to have multiple lung metastases 3 years after surgery and renal pelvic metastasis 4 years after surgery. The patient underwent robot-assisted laparoscopic radical nephroureterectomy and sleeve resection of the intramural segment of the ureter, and postoperative pathology and immunohistochemical staining confirmed the diagnosis of renal pelvic metastasis of breast angiosarcoma...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38576624/convergence-between-helminths-and-breast-cancer-intratumoral-injection-of-the-excretory-secretory-antigens-of-the-human-parasite-toxocara-canis-est-increase-lung-macro-and-micro-metastasis
#51
JOURNAL ARTICLE
Raúl Aragón-Franco, Rocío Alejandra Ruiz-Manzano, Karen Elizabeth Nava-Castro, Víctor Hugo Del Rìo Araiza, Claudia Angelica Garay-Canales, Armando Pérez-Torres, Romel Chacón-Salinas, Manuel Iván Girón-Pérez, Jorge Morales-Montor
INTRODUCTION: Worldwide, breast cancer is the most important cancer in incidence and prevalence in women. Different risk factors interact to increase the probability of developing it. Biological agents such as helminth parasites, particularly their excretory/secretory antigens, may play a significant role in tumor development. Helminths and their antigens have been recognized as inducers or promoters of cancer due to their ability to regulate the host's immune response. Previously in our laboratory, we demonstrated that chronic infection by Toxocara canis increases the size of mammary tumors, affecting the systemic response to the parasite...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38572023/halofuginone-guided-nano-local-therapy-nano-thermosensitive-hydrogels-for-postoperative-metastatic-canine-mammary-carcinoma-with-scar-removal
#52
JOURNAL ARTICLE
Runan Zuo, Lingqing Kong, Wanjun Pang, Shanxiang Jiang
In female dogs, the highest morbidity and mortality rates cancer are the result of mammary adenocarcinoma, which presents with metastases in the lung. Other than early surgical removal, however, no special methods are available to treat mammary adenocarcinoma. Because human breast cancer and canine mammary carcinoma share clinical characteristics and heterogeneity, the canine model is a suitable spontaneous tumor model for breast cancer in humans. In this study, the physical swelling method was used to prepare halofuginone-loaded D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) polymer micelles nano-thermosensitive hydrogels (HTPM-gel)...
June 2024: International journal of pharmaceutics: X
https://read.qxmd.com/read/38571938/discovery-of-an-independent-poor-prognosis-subtype-associated-with-tertiary-lymphoid-structures-in-breast-cancer
#53
JOURNAL ARTICLE
Ruiqi Liu, Xiaoqian Huang, Shiwei Yang, Wenbo Du, Xiaozhou Chen, Huamei Li
INTRODUCTION: Tertiary lymphoid structures (TLSs) are ectopic lymphoid formations that arise in non-lymphoid tissues due to chronic inflammation. The pivotal function of TLSs in regulating tumor invasion and metastasis has been established across several cancers, such as lung cancer, liver cancer, and melanoma, with a positive correlation between increased TLS presence and improved prognosis. Nevertheless, the current research about the clinical significance of TLSs in breast cancer remains limited...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38571902/case-report-emerging-brca-mutation-confers-benefit-from-olaparib-after-chemotherapy-intolerance-in-advanced-triple-negative-breast-cancer
#54
Xia-Bo Shen, Jia-Yi Wu, Jia-Ying Li, Xi-Ying Shao, Xiao-Jia Wang
KEY CLINICAL MESSAGE: In a patient with metastatic breast cancer, an acquired BRCA mutation in the BRCA gene was detected, resulting in benefits from olaparib treatment. This underscores the importance of ongoing genetic phenotype testing after paclitaxel chemotherapy. ABSTRACT: Triple-negative breast cancer (TNBC) is associated with a poor prognosis and elevated mortality risk. BRCA mutations are commonly regarded as prevalent mutations in TNBC patients, strongly associated with congenital familial heredity...
April 2024: Clinical Case Reports
https://read.qxmd.com/read/38571380/proteomic-and-metabolomic-characterization-of-bone-liver-and-lung-metastases-in-plasma-of-breast-cancer-patients
#55
JOURNAL ARTICLE
Hui Ye, Xiabo Shen, Yaohan Li, Weibin Zou, Syed Shams Ul Hassan, Yue Feng, Xiaojia Wang, Jingkui Tian, Xiying Shao, Yi Tao, Wei Zhu
BACKGROUND: Breast cancer (BC) is the second leading cause of cancer-related deaths among women, primarily due to metastases to other organs rather than the primary tumor. METHODS: In this study, a comprehensive analysis of plasma proteomics and metabolomics was conducted on a cohort of 51 BC patients. Potential biomarkers were screened by the Least Absolute Shrinkage and Selection Operator (LASSO) regression and Random Forest algorithm. Additionally, enzyme-linked immunosorbent assay (ELISA) kits and untargeted metabolomics were utilized to validate the prognostic biomarkers in an independent cohort...
April 3, 2024: Proteomics. Clinical Applications
https://read.qxmd.com/read/38566092/oncolytic-adenovirus-encoding-apolipoprotein-a1-suppresses-metastasis-of-triple-negative-breast-cancer-in-mice
#56
JOURNAL ARTICLE
Jie Dong, Lingkai Kong, Shiqun Wang, Mao Xia, Yenan Zhang, Jingyi Wu, Fuming Yang, Shuguang Zuo, Jiwu Wei
BACKGROUND: Dysregulation of cholesterol metabolism is associated with the metastasis of triple-negative breast cancer (TNBC). Apolipoprotein A1 (ApoA1) is widely recognized for its pivotal role in regulating cholesterol efflux and maintaining cellular cholesterol homeostasis. However, further exploration is needed to determine whether it inhibits TNBC metastasis by affecting cholesterol metabolism. Additionally, it is necessary to investigate whether ApoA1-based oncolytic virus therapy can be used to treat TNBC...
April 3, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38564478/iron-oxide-nanoparticles-inhibit-tumor-progression-and-suppress-lung-metastases-in-mouse-models-of-breast-cancer
#57
JOURNAL ARTICLE
Preethi Korangath, Lu Jin, Chun-Ting Yang, Sean Healy, Xin Guo, Suqi Ke, Cordula Grüttner, Chen Hu, Kathleen Gabrielson, Jeremy Foote, Robert Clarke, Robert Ivkov
Systemic exposure to starch-coated iron oxide nanoparticles (IONPs) can stimulate antitumor T cell responses, even when little IONP is retained within the tumor. Here, we demonstrate in mouse models of metastatic breast cancer that IONPs can alter the host immune landscape, leading to systemic immune-mediated disease suppression. We report that a single intravenous injection of IONPs can inhibit primary tumor growth, suppress metastases, and extend survival. Gene expression analysis revealed the activation of Toll-like receptor (TLR) pathways involving signaling via Toll/Interleukin-1 receptor domain-containing adaptor-inducing IFN-β (TRIF), a TLR pathway adaptor protein...
April 2, 2024: ACS Nano
https://read.qxmd.com/read/38564228/a-microfluidics-assisted-double-barreled-nanobioconjugate-synthesis-introducing-aprotinin-as-a-new-moonlight-nanocarrier-protein-tested-toward-physiologically-relevant-3d-spheroid-models
#58
JOURNAL ARTICLE
Faiqa Nazir, Iqra Munir, Gurkan Yesiloz
Proteins are promising substances for introducing new drug carriers with efficient blood circulation due to low possibilities of clearance by macrophages. However, such natural biopolymers have highly sophisticated molecular structures, preventing them from being assembled into nanoplatforms with manipulable payload release profiles. Here, we report a novel anticancer nanodrug carrier moonlighting protein, Aprotinin, to be used as a newly identified carrier for cytotoxic drugs. The Aprotinin-Doxorubicin (Apr-Dox) nanobioconjugate was prepared via a single-step microfluidics coflow mixing technique, a feasible and simple way to synthesize a carrier-based drug design with a double-barreled approach that can release and actuate two therapeutic agents simultaneously, i...
April 2, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38562905/circadian-rhythm-disruption-alters-mammary-gland-morphology-and-accelerates-cold-aggressive-tumorigenesis-through-a-lilrb4-dependent-pathway
#59
Olajumoke Ogunlusi, Mrinmoy Sarkar, Arhit Chakrabarti, Devon J Boland, Tristan Nguyen, James Sampson, Christian Nguyen, Danielle Fails, Yava Jones-Hall, Loning Fu, Bani Mallick, Alex Keene, Jeff Jones, Tapasree Roy Sarkar
UNLABELLED: Epidemiological studies have shown that circadian rhythm disruption (CRD) caused by shift work or frequent jet lag is associated with the risk of breast cancer development. However, the role of CRD in mammary gland morphology and aggressive mammary tumorigenesis and the molecular mechanisms underlying CRD and cancer risk remain unknown. We found that chronic CRD disrupted mouse mammary gland morphology and increased tumor burden and lung metastasis in a genetically engineered mouse model of aggressive breast cancer and induced an immunosuppressive tumor microenvironment by enhancing leukocyte immunoglobulin-like receptor 4a (LILRB4a or LILRB4) expression...
March 20, 2024: bioRxiv
https://read.qxmd.com/read/38559408/rectal-adenocarcinoma-in-the-eye-an-unexpected-destination
#60
Elias Edward Lahham, Mohammad I Alsahouri, Qusai A Alsalah, Salem Billan, Fadi Atrash
Colorectal cancer ranks third in cancer incidence in the United States, commonly metastasizing to the liver and lungs. Despite its high prevalence, colorectal cancer with intraocular metastasis is exceedingly rare, with only a few cases reported in the literature. This study presents a 58-year-old male, previously treated for rectal adenocarcinoma with liver and lung metastases, who developed choroidal metastasis causing visual impairment. Despite radiotherapy, moderate improvement was observed, and subsequent disease progression led to systemic chemotherapy...
2024: SAGE Open Medical Case Reports
keyword
keyword
72091
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.